ALNY logo

Alnylam Pharmaceuticals, Inc. (ALNY)

Profile

Full Name

Alnylam Pharmaceuticals, Inc.

Ticker

NASDAQ: ALNY

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 1, 2004

Indexes

Not included

Website

https://www.alnylam.com

Employees

2230

Key Details

Price

$454.38(-2.82%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.25B(+22.97% YoY)

Annual EPS

-$2.18(+38.07% YoY)

PE ratio

-

Next earnings date

Oct 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $454.38
    ALNY price is $454.38

    30-Day Relative Volume

    0.88
    ALNY 30-day relative volume is 0.88

    Price Performance

    Price Most recent change

    -2.82%
    ALNY price was down -2.82% on Aug 22, 2025

    Price YTD change

    +93.1%
    ALNY price is up +93.1% since January 1st

    Price 1-year change

    +63.84%
    ALNY price is up +63.84% year-on-year

    Price 3-year change

    +108.52%
    ALNY price is up +108.52% over the past 3 years

    Price Range

    Price All-time high

    $469.81
    ALNY price is currently -3.28% below its historical high of $469.81

    Price 3-year low

    $141.98
    ALNY price is currently +220.03% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $59.56B
    ALNY market capitalization is $59.56 billion

    Market cap 3-year change

    +127.72%
    ALNY market capitalization is up +127.72% over the past 3 years

    Market cap All-time high

    $61.29B
    ALNY market capitalization is currently -2.82% below its historical high of $61.29 billion

    Market cap sector rank

    97.59%
    ALNY market capitalization is higher than 97.59% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.1%
    ALNY shares outstanding is up +2.1% year-on-year

    Shares Outstanding 3-Year Change

    +9.21%
    ALNY shares outstanding is up +9.21% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.97
    ALNY beta is 0.97

    200-day SMA

    $284.26
    ALNY price is currently +59.85% above its 200-day simple moving average

    50-day SMA

    $360.01
    ALNY price is currently +26.21% above its 50-day simple moving average

    RSI

    75.50
    ALNY 14-day relative strength index is 75.50

    Volume

    0.88
    ALNY 30-day relative volume is 0.88

    ATR

    $13.38
    ALNY average true range is $13.38

    10-day Historical Volatility

    25.95%
    ALNY 10-day historical volatility is 25.95%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.25B
    ALNY annual revenue is $2.25 billion

    Revenue Analysts estimate

    $3.50B
    ALNY annual revenue is currently -35.79% lower than the consensus analysts' forecast

    Revenue 1-year change

    +22.97%
    ALNY annual revenue is up +22.97% year-on-year

    Revenue Sector rank

    89.68%
    ALNY annual revenue is higher than 89.68% of companies in Healthcare sector

    EPS

    EPS

    -$2.18
    ALNY annual earnings per share is -$2.18

    EPS Analysts estimate

    $3.92
    ALNY annual earnings per share is currently -155.64% lower than the consensus analysts' forecast

    EPS 1-year change

    +38.07%
    ALNY annual earnings per share is up +38.07% year-on-year

    EPS Sector rank

    35.69%
    ALNY annual earnings per share is higher than 35.69% of companies in Healthcare sector

    Profit

    Gross profit

    $1.92B
    ALNY annual gross profit is $1.92 billion

    Gross margin

    85.62%
    ALNY annual gross profit margin is 85.62%

    Operating profit

    -$176.88M
    ALNY annual operating income is -$176.88 million

    Operating margin

    -7.87%
    ALNY annual operating profit margin is -7.87%

    Net income

    -$278.16M
    ALNY annual net profit is -$278.16 million

    Net margin

    -12.37%
    ALNY annual net profit margin is -12.37%

    Expenses

    Total expenses

    $2.43B
    ALNY annual total expenses is $2.43 billion

    Operating expenses

    $2.10B
    ALNY annual total operating expenses is $2.10 billion

    Cost of goods sold

    $323.37M
    ALNY annual cost of goods sold is $323.37 million

    Selling, general & administrative expenses

    $975.53M
    ALNY annual SGA is $975.53 million

    Depreciation and amortization

    $56.67M
    ALNY annual depreciation & amortization is $56.67 million

    Interest expense

    $0.00
    ALNY annual interest expense is $0.00

    Income tax

    -$99.22M
    ALNY annual income tax is -$99.22 million

    EBIT & EBITDA

    EBIT

    -$235.52M
    ALNY annual earnings before interest & taxes is -$235.52 million

    EBITDA

    -$178.85M
    ALNY annual EBITDA is -$178.85 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $4.30B
    ALNY annual total assets is $4.30 billion

    Non current assets

    $944.70M
    ALNY annual long term assets is $944.70 million

    Current assets

    $3.30B
    ALNY annual total current assets is $3.30 billion

    Cash and cash equivalents

    $966.43M
    ALNY annual cash & cash equivalents is $966.43 million

    Accounts receivable

    $405.31M
    ALNY annual accounts receivable is $405.31 million

    Inventory

    $78.51M
    ALNY annual inventory is $78.51 million

    Liabilities

    Total liabilities

    $4.23B
    ALNY annual total liabilities is $4.23 billion

    Long term liabilities

    $2.99B
    ALNY annual total long term liabilities is $2.99 billion

    Current liabilities

    $1.19B
    ALNY annual total current liabilities is $1.19 billion

    Accounts payable

    $88.42M
    ALNY annual accounts payable is $88.42 million

    Debt

    Total debt

    $2.74B
    ALNY annual total debt is $2.74 billion

    Total debt 1-year change

    +2.27%
    ALNY annual total debt is up +2.27% year-on-year

    Long term debt

    $2.59B
    ALNY annual long term debt is $2.59 billion

    Short term debt

    $154.90M
    ALNY annual short term debt is $154.90 million

    Equity & Capital

    Shareholders equity

    $67.09M
    ALNY annual stockholders equity is $67.09 million

    Book value

    $67.09M
    ALNY annual book value is $67.09 million

    Retained earnings

    -$7.29B
    ALNY annual retained earnings is -$7.29 billion

    Working capital

    $2.11B
    ALNY annual working capital is $2.11 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$8.31M
    ALNY annual cash flow from operations is -$8.31 million

    Cash from operations 1-year change

    -107.98%
    ALNY annual cash flow from operations is down -107.98% year-on-year

    Cash from investing

    -$116.84M
    ALNY annual cash flow from investing activities is -$116.84 million

    Cash from investing 1-year change

    +65.26%
    ALNY annual cash flow from investing activities is up +65.26% year-on-year

    Cash from financing

    $294.16M
    ALNY annual cash flow from financing activities is $294.16 million

    Cash from financing 1-year change

    +70.89%
    ALNY annual cash flow from financing activities is up +70.89% year-on-year

    CAPEX

    CAPEX

    $34.28M
    ALNY annual capital expenditures is $34.28 million

    CAPEX 1-year change

    -44.9%
    ALNY annual capital expenditures is down -44.9% year-on-year

    Free Cash Flow

    Free cash flow

    -$42.59M
    ALNY annual free cash flow is -$42.59 million

    Free cash flow 1-year change

    -201.54%
    ALNY annual free cash flow is down -201.54% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    85.62%
    ALNY annual gross profit margin is 85.62%

    Operating margin

    -7.87%
    ALNY annual operating profit margin is -7.87%

    Net margin

    -12.37%
    ALNY annual net profit margin is -12.37%

    ROA & ROE

    ROA

    -6.84%
    ALNY annual return on assets is -6.84%

    ROE

    -414.62%
    ALNY annual return on equity is -414.62%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ALNY price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ALNY price to earnings ratio is unknown

    PB Ratio

    PB ratio

    237.68
    ALNY price to book ratio is 237.68

    PB ratio Sector rank

    99.75%
    ALNY price to book ratio is higher than 99.75% of companies in Healthcare sector

    PS Ratio

    PS ratio

    24.19
    ALNY price to sales ratio is 24.19

    PS ratio Sector rank

    82.29%
    ALNY price to sales ratio is higher than 82.29% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $59.44B
    ALNY enterprise value is $59.44 billion

    Enterprise value Sector rank

    97.57%
    ALNY enterprise value is higher than 97.57% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -395.51
    ALNY EV/EBITDA is -395.51

    EV/EBITDA Sector rank

    0.27%
    ALNY EV/EBITDA is higher than 0.27% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.78
    ALNY annual current ratio is 2.78

    Quick ratio

    2.71
    ALNY annual quick ratio is 2.71

    Leverage

    Debt to equity

    40.89
    ALNY annual debt to equity ratio is 40.89

    Interest coverage ratio

    -
    ALNY annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    2
    ALNY piotroski f-score is 2

    Altman Z-Score

    7.00
    ALNY altman z-score is 7.00

    Analyst ratings

    Recent major analysts updates

    Aug 7, 25 HC Wainwright & Co.
    Buy
    Aug 6, 25 JP Morgan
    Overweight
    Aug 4, 25 Wolfe Research
    Peer Perform
    Aug 4, 25 Oppenheimer
    Outperform
    Aug 1, 25 Wells Fargo
    Equal-Weight
    Aug 1, 25 UBS
    Buy
    Aug 1, 25 Scotiabank
    Sector Outperform
    Aug 1, 25 Raymond James
    Outperform
    Aug 1, 25 Piper Sandler
    Overweight
    Aug 1, 25 Morgan Stanley
    Equal-Weight

    Institutional Ownership

    Screeners with ALNY included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last 3 years
    Stocks above analysts price target
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    • What is the ticker symbol for Alnylam Pharmaceuticals, Inc.?
    • Does Alnylam Pharmaceuticals, Inc. pay dividends?
    • What sector is Alnylam Pharmaceuticals, Inc. in?
    • What industry is Alnylam Pharmaceuticals, Inc. in?
    • What country is Alnylam Pharmaceuticals, Inc. based in?
    • When did Alnylam Pharmaceuticals, Inc. go public?
    • Is Alnylam Pharmaceuticals, Inc. in the S&P 500?
    • Is Alnylam Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Alnylam Pharmaceuticals, Inc. in the Dow Jones?
    • When was Alnylam Pharmaceuticals, Inc.'s last earnings report?
    • When does Alnylam Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Alnylam Pharmaceuticals, Inc.?

    The ticker symbol for Alnylam Pharmaceuticals, Inc. is NASDAQ:ALNY

    Does Alnylam Pharmaceuticals, Inc. pay dividends?

    No, Alnylam Pharmaceuticals, Inc. does not pay dividends

    What sector is Alnylam Pharmaceuticals, Inc. in?

    Alnylam Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Alnylam Pharmaceuticals, Inc. in?

    Alnylam Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Alnylam Pharmaceuticals, Inc. based in?

    Alnylam Pharmaceuticals, Inc. is headquartered in United States

    When did Alnylam Pharmaceuticals, Inc. go public?

    Alnylam Pharmaceuticals, Inc.'s initial public offering (IPO) was on June 1, 2004

    Is Alnylam Pharmaceuticals, Inc. in the S&P 500?

    No, Alnylam Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Alnylam Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Alnylam Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Alnylam Pharmaceuticals, Inc. in the Dow Jones?

    No, Alnylam Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Alnylam Pharmaceuticals, Inc.'s last earnings report?

    Alnylam Pharmaceuticals, Inc.'s most recent earnings report was on July 31, 2025

    When does Alnylam Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Alnylam Pharmaceuticals, Inc. is October 30, 2025
    On this page